Physician profile
Michael Panutich
NPI 1245421445
$39,305.38
in general payments reported to CMS, 2019-2025
26 companies · $9,727 in 2025
The $9,727 reported for 2025 was more than what 80% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,513 · 2020: $4,086 · 2021: $7,403 · 2022: $2,112 · 2023: $3,153 · 2024: $9,311 · 2025: $9,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $3,350 · Travel and Lodging: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,550.00 |
| Food and Beverage | $3,349.72 |
| Travel and Lodging | $1,291.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $16,918.00 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Visitag Surpoint External Processing Unit |
| Medical Device Business Services, INC. | $9,000.00 | 2023-2024 | Carto 3 |
| Atricure, INC. | $6,721.99 | 2019-2024 | |
| Boston Scientific Corporation | $2,385.11 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Rhythmia Mapping System |
| Acutus Medical, INC. | $1,388.95 | 2019-2022 | |
| Medtronic, INC. | $684.79 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Attain Command + Surevalve |
| Cardiva Medical, INC. | $503.72 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire, Ensoetm |
| Biotronik INC. | $303.10 | 2019-2025 | |
| Abbott Laboratories | $294.60 | 2019-2025 | Gallant, Jot Dx |
| Novartis Pharmaceuticals Corporation | $213.38 | 2023-2025 | |
| Medtronic Vascular, INC. | $164.78 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $137.91 | 2022-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $91.59 | 2019-2023 | Xarelto |
| Amgen INC. | $88.97 | 2019-2025 | Repatha |
| Kestra Medical Technology Services, INC. | $88.47 | 2023-2025 | Assure Wcd |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $78.76 | 2020-2022 | |
| Cvrx, INC. | $53.22 | 2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.79 | 2025 | Lifevest |
| Abiomed | $27.87 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $24.31 | 2024 | Evkeeza |
| Altathera Pharmaceuticals LLC | $20.52 | 2025 | Sotalol Hydrochloride |
| Teleflex LLC | $19.37 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.48 | 2022 | |
| Esperion Therapeutics, INC. | $15.41 | 2020 | |
| Ge Healthcare | $15.37 | 2020 | |
| Cardiovascular Systems INC. | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Panutich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.